Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 15.09
- Piotroski Score 2.00
- Grade Perform
- Symbol (HMA)
- Company Heartland Media Acquisition Corp.
- Price $10.54
- Changes Percentage (-0.57%)
- Change -$0.06
- Day Low $10.54
- Day High $10.55
- Year High $10.86
Heartland Media Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. It intends to acquire businesses or entities in the media, entertainment, and sports sectors. Heartland Media Acquisition Corp. was incorporated in 2021 and is based in Atlanta, Georgia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/30/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.11
- Trailing P/E Ratio 95.818181818182
- Forward P/E Ratio 95.818181818182
- P/E Growth 95.818181818182
- Net Income $10.68 M
Income Statement
Quarterly
Annual
Latest News of HMA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Popular asthma drug may be linked to serious mental health problems
Recent findings show that the asthma drug Singulair, manufactured by Merck & Co, may be linked to serious mental health issues. The FDA added a black box warning in 2020 after reports of neuropsychiat...
By New York Post | 22 hours ago -
Exclusive-US FDA finds widely used asthma drug impacts the brain
Recent research suggests a link between the asthma drug Singulair and mental health issues. FDA reports show neuropsychiatric episodes, leading to a "black box" warning in 2020. Further studies are ne...
By Yahoo! Finance | 1 day ago -
Confluent Hits 80-Plus Relative Strength Rating Benchmark
The Relative Strength Rating by IBD measures stock price performance from 1 to 99. A high RS Rating indicates potential for big gains. It's a key indicator for finding top stocks and assessing their g...
By Investor's Business Daily | 1 day ago
